XML 35 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Sep. 30, 2014
Summary of Significant Accounting Policies  
Schedule of the Company's net sales by medical indication

(In thousands)

 

Three Months Ended
September 30,

 

Medical Indication

 

2014

 

2013

 

Antibiotic

 

$
3,003 

 

$
3,375 

 

Cardiovascular

 
18,939 

 
4,524 

 

Gallstone

 
11,761 

 
1,366 

 

Glaucoma

 
4,691 

 
1,455 

 

Gout

 
2,299 

 
2,053 

 

Migraine

 
5,795 

 
2,715 

 

Obesity

 
915 

 
1,131 

 

Pain Management

 
6,655 

 
5,218 

 

Thyroid Deficiency

 
33,346 

 
20,027 

 

Other

 
5,983 

 
3,965 

 

Total

 

$
93,387 

 

$
45,829 

 

 

Summary of products which accounted for at least 10% of net sales

 

 

2014

 

2013

 

 

 

 

 

 

 

Product 1

 
36 

%
44 

%

Product 2

 
19 

%
6 

%

Product 3

 
13 

%
3 

%

 

Summary of customers which accounted for at least 10% of net sales

 

 

2014

 

2013

 

 

 

 

 

 

 

Customer A

 
31 

%
14 

%

Customer B

 
9 

%
11 

%

Customer C

 
0 

%
16 

%